Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2/3 study of HP-3150 in patients with cancer pain
jRCT2080222905Phase 3
- Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Start
- Jul 2015
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cancer pain comparing HP-3150 with Placebo (2 arms).
02
Drugs
HP-5000
03
Conditions
cancer pain
Beyond the preview
Go deeper on jRCT2080222905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222905.